TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q2 2022

TFF Pharmaceuticals, Inc. (NASDAQ:NASDAQ:TFFP) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO...

Related Keywords

Paris , France General , France , Australia , Melbourne , Victoria , Canada , Texas , United States , University Of Texas , Jordan , Kirk Coleman , Bradley Gardiner , John Koleng , Michael Okunewitch , Dale Christensen , Bill Williams , Corey Davis , Daniel Carlson , Donald Owens , Jonathan Aschoff , Malcolm Fairbairn , Company Participants , Nasdaq , Tw Research Group , International Journal Of Pharmaceutics , Members Of The Congressional Appropriations Committee , Product Development , Maxim Group , Tff Pharmaceuticals Inc , Lung Transplant Congress , Biopharm International , Clinical Development , Pharmaceuticals Second Quarter , Human Services , International Congress On Lung Transplantation , University Of Texas At Austin , Exchange Commission , Conference Call August , Second Quarter , Glenn Mattes , Chief Financial Officer , Chris Cano , Risk Factors , Thin Film Freezing , Thin Film , Improved Formulations , Enable Stable Delivery , Film Freezing , International Journal , Best Paper Award , Voriconazole Inhalation Powder , Tacrolimus Inhalation Powder , Torreya Partners , Royal Alfred Hospital , Compassionate Use Study , International Congress , Lung Transplantation , Inhaled Niclosamide , Niclosamide Phase , Niclosamide Inhalation Powder , Glass House , Congressional Appropriations Committee , Compassionate Use , Thanks Glenn ,